Search details
1.
Molecular Profiling Provides Clinical Insights Into Targeted and Immunotherapies as Well as Colorectal Cancer Prognosis.
Gastroenterology
; 165(2): 414-428.e7, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37146911
2.
Utility of Circulating Free DNA Fragmentomics in the Prediction of Pathological Response after Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
Clin Chem
; 69(1): 88-99, 2023 01 04.
Article
in English
| MEDLINE | ID: mdl-36308331
3.
Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection.
Mol Cancer
; 21(1): 129, 2022 06 11.
Article
in English
| MEDLINE | ID: mdl-35690859
4.
The pattern and treatment outcomes for rectal cancer with concurrent locoregional recurrence and distant metastases after total mesorectal excision.
BMC Cancer
; 22(1): 1088, 2022 Oct 24.
Article
in English
| MEDLINE | ID: mdl-36280830
5.
Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: a randomized, prospective, multicentre, double-arm, phase II trial (TORCH).
BMC Cancer
; 22(1): 274, 2022 Mar 15.
Article
in English
| MEDLINE | ID: mdl-35291966
6.
HER2 status is positively associated with vessel invasion of colorectal cancer: a retrospective large cohort study.
Int J Colorectal Dis
; 37(9): 2061-2067, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-36006442
7.
Performance of common genetic variants in risk prediction for colorectal cancer in Chinese: A two-stage and multicenter study.
Genomics
; 113(3): 867-873, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33545268
8.
Novel functional variants in the Notch pathway and survival of Chinese colorectal cancer.
Int J Cancer
; 149(1): 84-96, 2021 07 01.
Article
in English
| MEDLINE | ID: mdl-33728681
9.
Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study.
PLoS Med
; 18(8): e1003741, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34464382
10.
A novel human colon signet-ring cell carcinoma organoid line: establishment, characterization and application.
Carcinogenesis
; 41(7): 993-1004, 2020 07 14.
Article
in English
| MEDLINE | ID: mdl-31740922
11.
Development and validation of a novel epigenetic signature for predicting prognosis in colon cancer.
J Cell Physiol
; 235(11): 8714-8723, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32329069
12.
Immunohistochemistry-Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer.
Oncologist
; 25(12): e1968-e1979, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32926498
13.
Establishment and validation of a novel nomogram incorporating clinicopathological parameters into the TNM staging system to predict prognosis for stage II colorectal cancer.
Cancer Cell Int
; 20: 285, 2020.
Article
in English
| MEDLINE | ID: mdl-32655317
14.
Increasing age-related survival gap among patients with colorectal cancer: a population-based retrospective study.
Int J Clin Oncol
; 25(1): 100-109, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31531787
15.
Epithelial EZH2 serves as an epigenetic determinant in experimental colitis by inhibiting TNFα-mediated inflammation and apoptosis.
Proc Natl Acad Sci U S A
; 114(19): E3796-E3805, 2017 05 09.
Article
in English
| MEDLINE | ID: mdl-28439030
16.
Clinicopathologic features and prognostic value of KRAS, NRAS and BRAF mutations and DNA mismatch repair status: A single-center retrospective study of 1,834 Chinese patients with Stage I-IV colorectal cancer.
Int J Cancer
; 145(6): 1625-1634, 2019 09 15.
Article
in English
| MEDLINE | ID: mdl-31162857
17.
Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis.
Oncologist
; 24(6): 803-811, 2019 06.
Article
in English
| MEDLINE | ID: mdl-29674444
18.
Adjuvant chemotherapy for rectal cancer with complete pathological response (pCR) may not be necessary: a pooled analysis of 5491 patients.
Cancer Cell Int
; 19: 127, 2019.
Article
in English
| MEDLINE | ID: mdl-31114447
19.
Prognostic nomograms for predicting cause-specific survival and overall survival of stage I-III colon cancer patients: a large population-based study.
Cancer Cell Int
; 19: 355, 2019.
Article
in English
| MEDLINE | ID: mdl-31889907
20.
ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial.
BMC Cancer
; 19(1): 1117, 2019 Nov 15.
Article
in English
| MEDLINE | ID: mdl-31729964